−0.005AUD
−1.92 MAUD
About HEXIMA LIMITED.
Sector
Industry
CEO
Geoffrey Paul Kempler
Website
Headquarters
Carlton
Founded
1998
ISIN
AU0000111932
FIGI
BBG000R1TW69
Hexima Ltd. is a clinical stage, anti-infectives focused biotechnology company. It engages in the business of researching and developing plant-derived proteins for applications as human therapeutics. The company was founded by Adrienne E. Clarke, Marilyn Ann Anderson, Robyn L. Heath, and Angela Atkinson in 1998 and is headquartered in Preston, Australia.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of HXL is 0.01 AUD — it has increased by 9.09% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange HEXIMA LIMITED. stocks are traded under the ticker HXL.
HEXIMA LIMITED. is going to release the next earnings report on Aug 28, 2024. Keep track of upcoming events with our Earnings Calendar.
HXL earnings for the last quarter are −0.03 AUD whereas the estimation was −3.10 AUD which accounts for 99.16% surprise. Estimated earnings for the next quarter are −0.02 AUD. See more details about HEXIMA LIMITED. earnings.
Yes, you can track HEXIMA LIMITED. financials in yearly and quarterly reports right on TradingView.
Like other stocks, HXL shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HEXIMA LIMITED. stock right from TradingView charts — choose your broker and connect to your account.